JP2001047044A - Method for treating water containing endocrine disrupting substances - Google Patents
Method for treating water containing endocrine disrupting substancesInfo
- Publication number
- JP2001047044A JP2001047044A JP11228034A JP22803499A JP2001047044A JP 2001047044 A JP2001047044 A JP 2001047044A JP 11228034 A JP11228034 A JP 11228034A JP 22803499 A JP22803499 A JP 22803499A JP 2001047044 A JP2001047044 A JP 2001047044A
- Authority
- JP
- Japan
- Prior art keywords
- water
- endocrine disrupting
- membrane
- substance
- disrupting substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Separation Using Semi-Permeable Membranes (AREA)
- Removal Of Specific Substances (AREA)
- Treatment Of Water By Oxidation Or Reduction (AREA)
Abstract
(57)【要約】
【課題】水中に微量に含まれる内分泌撹乱性物質を選択
的に分解除去して、低コストで無害化することができる
内分泌撹乱性物質含有水の処理方法を提供する。
【解決手段】内分泌撹乱性物質含有水を、触媒機能を有
する疎水性膜に通水することを特徴とする内分泌撹乱性
物質含有水の処理方法。
(57) [Summary] [Object] To provide a method for treating endocrine disrupting substance-containing water which can be detoxified at low cost by selectively decomposing and removing endocrine disrupting substances contained in a trace amount in water. An endocrine disrupting substance-containing water is passed through a hydrophobic membrane having a catalytic function to treat endocrine disrupting substance-containing water.
Description
【0001】[0001]
【発明の属する技術分野】本発明は、内分泌撹乱性物質
含有水の処理方法に関する。さらに詳しくは、本発明
は、水中に微量に含まれる内分泌撹乱性物質を選択的に
分解除去して、低コストで無害化することができる内分
泌撹乱性物質含有水の処理方法に関する。The present invention relates to a method for treating water containing endocrine disrupting substances. More specifically, the present invention relates to a method for treating endocrine disrupting substance-containing water that can be detoxified at low cost by selectively decomposing and removing endocrine disrupting substances contained in a trace amount in water.
【0002】[0002]
【従来の技術】近年、多くの地域で見られる野生生物の
生殖障害には、一般に環境ホルモンと呼ばれる外因性内
分泌撹乱化学物質が関与しているのではないかという疑
念が抱かれ、内分泌撹乱性物質に対する関心が高まって
いる。内分泌撹乱性物質とは、外因性内分泌撹乱化学物
質のほか、生体ホルモンや合成ホルモンなど、生物の体
内に入ると内分泌系を撹乱し、生殖障害など健康や生態
系に悪影響を与える物質である。このうち、外因性内分
泌撹乱化学物質については、環境庁が1997年に外因
性内分泌撹乱化学物質問題に関する研究班中間報告書に
おいて、外因性内分泌撹乱化学物質としての疑いのある
物質として67種の化学物質(群)を挙げている。すなわ
ち、ダイオキシン類、ポリ塩化ビフェニール類(PC
B)、ポリ臭化ビフェニール類(PBB)、ヘキサクロ
ロベンゼン(HCB)、ペンタクロロフェノール(PC
P)、2,4,5−トリクロロフェノキシ酢酸、2,4−
ジクロロフェノキシ酢酸、アミトロール、アトラジン、
アラクロール、シマジン、ヘキサクロロシクロヘキサ
ン、エチルパラチオン、カルバリル、クロルデン、オキ
シクロルデン、trans−ノナクロル、1,2−ジブロモ−
3−クロロプロパン、DDT、DDE、DDD、ケルセ
ン、アルドリン、エンドリン、ティルドリン、エンドス
ルファン(ベンゾエピン)、ヘプタクロル、ヘプタクロ
ルエポキサイド、マラチオン、メソミル、メトキシクロ
ル、マイレックス、ニトロフェン、トキサフェン、トリ
ブチルスズ、トリフェニルスズ、トリフルラリン、アル
キルフェノール(C5)、ノニルフェノール、4−オク
チルフェノール、ビスフェノールA、フタル酸ジ−2−
エチルヘキシル、フタル酸ブチルベンジル、フタル酸ジ
−n−ブチル、フタル酸ジシクロヘキシル、フタル酸ジ
エチル、ベンゾ(a)ピレン、2,4−ジクロロフェノー
ル、アジピン酸ジ−2−エチルヘキシル、ベンゾフェノ
ン、4−ニトロトルエン、オクタクロロスチレン、アル
ディカーブ、ベノミル、キーポン(クロルデコン)、マ
ンゼブ(マンコゼブ)、マンネブ、メチラム、メトリブ
ジン、ジペルメトリン、エスフェンバレレート、フェン
バレレート、ペルメトリン、ビンクロゾリン、ジネブ、
ジラム、フタル酸ジペンチル、フタル酸ジヘキシル、フ
タル酸ジプロピル、スチレンの2及び3量体、n−ブチ
ルベンゼンの物質又は物質群である。内分泌撹乱性物質
は、樹脂素材、可塑剤、界面活性剤、染料及びその原
料、農薬などの広い領域で工業的に生産、使用されてい
るもの、薬品製造工程やゴミ焼却などの過程で非意図的
に発生するもの、自然界で生産されるものなどがあり、
用水、排水、河川、湖沼、海水、土壌、地下水、底泥な
どの中に広く分布していることが指摘され、大きな社会
問題となっている。これらの物質は、生体内に取り込ま
れたとき、甲状腺ホルモン、性ホルモン、副腎皮質刺激
ホルモンなどのように、人体や他の生物に作用し、水環
境ではng/リットル〜μg/リットルレベルの極微量
でも影響を与えることが報告されている。内分泌撹乱性
物質の作用メカニズムについては、いまだ科学的知見が
十分に得られておらず、現時点では国内外で内分泌撹乱
性物質に対しての環境規制は行われていない。上記の研
究班中間報告の中に挙げられている物質(群)も、外因性
内分泌撹乱化学物質として特定されたわけではない。そ
れゆえ、今後の研究結果によって、これらの物質(群)以
外にも内分泌撹乱性物質とされる物質(群)が特定される
可能性がある。従来より、水中に存在する有害有機化合
物の除去技術としては、生物分解、オゾンや過酸化水素
などによる酸化分解などが検討、提案されている。特定
有害物質の分解除去を目的とした生物処理には、特定の
真菌や細菌による分解処理、活性汚泥などの混合微生物
を特定物質で馴養したものによる分解処理などが挙げら
れる。これらの処理は、処理対象の物質が特定されてい
る場合には優れた方法であるが、水中に多種類の化合
物、特に内分泌撹乱性物質が存在する場合には、それら
をすべて効率よく除去することは困難である。また、mg
/リットルレベルの分解対象化合物を含む水溶液中で馴
養、分離した混合微生物や単離株は、μg/リットルレ
ベルの極低濃度で含まれる分解対象化合物の処理に対し
て必ずしも親和性が強いとはいえない。酸化剤による処
理法としては、オゾンや過酸化水素などの強力な酸化剤
を用いる方法が検討されている。これらは酸化力が強
く、多種類の化合物を分解することができるという特徴
を有する。しかし、mg/リットルレベルと比較して、μ
g/リットルレベルの極低濃度では、対象化合物量あた
り必要とされる酸化剤の量が多くなり、経済的に好まし
くない。2. Description of the Related Art In recent years, it has been suspected that endogenous endocrine disrupting chemicals, generally called environmental hormones, are involved in reproductive disorders of wildlife found in many areas. Interest in materials is growing. An endocrine disrupting substance is a substance, such as an exogenous endocrine disrupting chemical substance, a living hormone or a synthetic hormone, which disturbs the endocrine system when entering the body of an organism and adversely affects the health and ecosystem such as reproductive disorders. Among these, exogenous endocrine disrupting chemicals were identified by the Environment Agency in 1997 in the Interim Report on the Study Group on the Problem of Exogenous Endocrine Disrupting Chemicals as 67 substances suspected to be endogenous endocrine disrupting chemicals. The substance (group) is listed. That is, dioxins, polychlorinated biphenyls (PC
B), polybrominated biphenyls (PBB), hexachlorobenzene (HCB), pentachlorophenol (PC
P) 2,4,5-trichlorophenoxyacetic acid, 2,4-
Dichlorophenoxyacetic acid, amitrol, atrazine,
Arachlor, simazine, hexachlorocyclohexane, ethyl parathion, carbaryl, chlordane, oxychlordane, trans-nonachlor, 1,2-dibromo-
3-chloropropane, DDT, DDE, DDD, quercene, aldrin, endrin, tildoline, endosulfan (benzoepine), heptachlor, heptachlorepoxide, malathion, mesomil, methoxychlor, mylex, nitrofen, toxaphen, tributyltin, triphenyltin, trifluralin, alkylphenol (C5), nonylphenol, 4-octylphenol, bisphenol A, di-2-phthalic acid
Ethylhexyl, butylbenzyl phthalate, di-n-butyl phthalate, dicyclohexyl phthalate, diethyl phthalate, benzo (a) pyrene, 2,4-dichlorophenol, di-2-ethylhexyl adipate, benzophenone, 4-nitrotoluene, Octachlorostyrene, Aldicarb, Benomyl, Keepon (chlordecone), Manzeb (Mancozeb), Maneb, Methyram, Metribuzin, Dipermethrin, Esfenvalerate, Fenvalerate, Permethrin, Vinclozolin, Zineb,
It is a substance or substance group of diram, dipentyl phthalate, dihexyl phthalate, dipropyl phthalate, dimer and trimer of styrene, and n-butylbenzene. Endocrine disruptors are industrially produced and used in a wide range of areas, such as resin materials, plasticizers, surfactants, dyes and their raw materials, and pesticides. Some are naturally occurring, some are produced in nature,
It has been pointed out that it is widely distributed in water, drainage, rivers, lakes, marshes, seawater, soil, groundwater, sediment, etc., and has become a major social problem. When these substances are taken into a living body, they act on the human body and other organisms, such as thyroid hormone, sex hormone, and adrenocorticotropic hormone. Even small amounts have been reported to have an effect. Sufficient scientific knowledge has not yet been obtained regarding the mechanism of action of endocrine disrupting substances, and at present, no environmental regulations have been imposed on endocrine disrupting substances at home and abroad. The substance (s) listed in the above interim report of the research group were not identified as exogenous endocrine disrupting chemicals. Therefore, future research results may identify substances (group) that are considered endocrine disrupting substances in addition to these substances (group). Conventionally, biodegradation, oxidative decomposition with ozone, hydrogen peroxide, and the like have been studied and proposed as techniques for removing harmful organic compounds present in water. Examples of biological treatment for the purpose of decomposing and removing specific harmful substances include decomposition treatment with specific fungi and bacteria, and decomposition treatment with a mixture of microorganisms such as activated sludge acclimated with a specific substance. These treatments are excellent when the substance to be treated is specified, but when there are many kinds of compounds in the water, especially when endocrine disrupting substances are present, they are all efficiently removed. It is difficult. Also, mg
Mixed microorganisms and isolates that have been acclimated and separated in an aqueous solution containing a decomposition target compound at the level of 1 / liter do not necessarily have a strong affinity for treatment of the decomposition target compound contained at an extremely low concentration of the μg / liter level. I can't say. As a treatment method using an oxidizing agent, a method using a strong oxidizing agent such as ozone or hydrogen peroxide has been studied. They have a strong oxidizing power and are capable of decomposing various kinds of compounds. However, compared to the mg / liter level, μ
At an extremely low concentration of g / liter, the amount of the oxidizing agent required per amount of the target compound increases, which is not economically preferable.
【0003】[0003]
【発明が解決しようとする課題】本発明は、水中に微量
に含まれる内分泌撹乱性物質を選択的に分解除去して、
低コストで無害化することができる内分泌撹乱性物質含
有水の処理方法を提供することを目的としてなされたも
のである。SUMMARY OF THE INVENTION The present invention is to selectively decompose and remove endocrine disrupting substances contained in a trace amount in water,
An object of the present invention is to provide a method for treating endocrine disrupting substance-containing water that can be made harmless at low cost.
【0004】[0004]
【課題を解決するための手段】本発明者らは、上記の課
題を解決すべく鋭意研究を重ねた結果、内分泌撹乱性物
質を含有する水に酸化剤又は還元剤を添加し、触媒機能
を有する疎水性膜に通水することにより、水中に含有さ
れる内分泌撹乱性物質を選択的に分解除去し得ることを
見いだし、この知見に基づいて本発明を完成するに至っ
た。すなわち、本発明は、(1)内分泌撹乱性物質含有
水を、触媒機能を有する疎水性膜に通水することを特徴
とする内分泌撹乱性物質含有水の処理方法、(2)内分
泌撹乱性物質含有水に酸化剤を添加し、触媒機能を有す
る疎水性膜に通水する第(1)項記載の内分泌撹乱性物質
含有水の処理方法、(3)内分泌撹乱性物質含有水に酸
化剤を添加し、紫外線照射下に触媒機能を有する疎水性
膜に通水する第(2)項記載の内分泌撹乱性物質含有水の
処理方法、(4)内分泌撹乱性物質含有水を、紫外線照
射下に触媒機能を有する疎水性膜に通水する第(1)項記
載の内分泌撹乱性物質含有水の処理方法、(5)内分泌
撹乱性物質含有水に還元剤を添加し、触媒機能を有する
疎水性膜に通水する第(1)項記載の内分泌撹乱性物質含
有水の処理方法、及び、(6)触媒機能を有する疎水性
膜が、表面を親水性化した疎水性膜に金属又は金属酸化
物の触媒を担持させたものである第(1)項記載の内分泌
撹乱性物質含有水の処理方法、を提供するものである。Means for Solving the Problems The present inventors have conducted intensive studies to solve the above-mentioned problems, and as a result, added an oxidizing agent or a reducing agent to water containing an endocrine-disrupting substance to thereby improve the catalytic function. It has been found that the endocrine disrupting substance contained in the water can be selectively decomposed and removed by passing water through the hydrophobic membrane, and the present invention has been completed based on this finding. That is, the present invention provides (1) a method for treating endocrine disrupting substance-containing water, which comprises passing the endocrine disrupting substance-containing water through a hydrophobic membrane having a catalytic function, and (2) an endocrine disrupting substance. (1) The method for treating water containing an endocrine disrupting substance according to (1), wherein the oxidizing agent is added to the water containing the oxidizing agent, and the water is passed through a hydrophobic membrane having a catalytic function. The method for treating endocrine disrupting substance-containing water according to (2), wherein the water is added and passed through a hydrophobic membrane having a catalytic function under ultraviolet irradiation. (4) The endocrine disrupting substance-containing water is treated under ultraviolet irradiation. (1) The method for treating water containing an endocrine disrupting substance according to (1), wherein the water is passed through a hydrophobic membrane having a catalytic function. (5) A hydrophobic agent having a catalytic function is added to the water containing an endocrine disrupting substance. The method for treating endocrine disrupting substance-containing water according to (1), wherein the water is passed through the membrane, and 6) Treatment of endocrine disrupting substance-containing water according to item (1), wherein the hydrophobic film having a catalytic function is obtained by supporting a metal or metal oxide catalyst on a hydrophobic film having a hydrophilic surface. Method.
【0005】[0005]
【発明の実施の形態】本発明の内分泌撹乱性物質含有水
の処理方法は、上記の現在外因性内分泌撹乱化学物質と
しての疑いがもたれている物質や、将来外因性内分泌撹
乱化学物質として特定される物質、また、生体ホルモン
や合成ホルモンなど、内分泌系を撹乱するおそれのある
物質を含有する水に対して適用することができる。本発
明方法は、内分泌撹乱性物質を1μg/リットル〜5mg
/リットルの濃度で含有する水の処理に適しており、さ
らに、内分泌撹乱性物質のうち疎水性のものを含有する
水の処理に適している。本発明方法を適用する内分泌撹
乱性物質含有水のpHに特に制限はなく、pH1〜13の広
い範囲において適用することができるが、pH5〜9にお
いて適用することが特に好ましい。本発明方法に用いる
疎水性膜の材質に特に制限はなく、例えば、ポリプロピ
レン膜、ポリジメチルシロキサン膜、ポリ(4−メチル
ペンテン−1)膜、ポリ(2,6−ジメチルフェニレンオ
キシド)膜、ポリフッ化ビニリデン膜、ポリテトラフル
オロエチレン膜などを挙げることができる。内分泌撹乱
性物質含有水に酸化剤を添加する場合は、耐酸化性に優
れるポリテトラフルオロエチレン膜やポリフッ化ビニリ
デン膜を用いることが好ましい。本発明方法に用いる疎
水性膜の孔径は、0.01〜2μmであることが好まし
く、0.05〜1μmであることがより好ましい。本発
明方法に用いる疎水性膜の形態に特に制限はなく、例え
ば、平膜、スパイラル膜、中空糸などを挙げることがで
きる。内分泌撹乱性物質含有水に紫外線を照射する場合
は、平膜及び中空糸を好適に用いることができる。BEST MODE FOR CARRYING OUT THE INVENTION The method for treating endocrine disrupting substance-containing water according to the present invention is specified as the above-mentioned substance suspected as an exogenous endocrine disrupting chemical at present, or as an exogenous endocrine disrupting chemical in the future. And water containing substances that may disrupt the endocrine system, such as living hormones and synthetic hormones. In the method of the present invention, an endocrine disrupting substance is contained in an amount of 1 μg / liter to 5 mg.
1 / liter and suitable for treating water containing hydrophobic endocrine disrupting substances. The pH of the endocrine disrupting substance-containing water to which the method of the present invention is applied is not particularly limited, and it can be applied in a wide range of pH 1 to 13, but is particularly preferably applied in a pH range of 5 to 9. The material of the hydrophobic film used in the method of the present invention is not particularly limited, and examples thereof include a polypropylene film, a polydimethylsiloxane film, a poly (4-methylpentene-1) film, a poly (2,6-dimethylphenylene oxide) film, and a polyfluorinated film. A vinylidene fluoride film, a polytetrafluoroethylene film, and the like can be given. When an oxidizing agent is added to the endocrine disrupting substance-containing water, it is preferable to use a polytetrafluoroethylene film or a polyvinylidene fluoride film having excellent oxidation resistance. The pore size of the hydrophobic membrane used in the method of the present invention is preferably from 0.01 to 2 μm, more preferably from 0.05 to 1 μm. The form of the hydrophobic membrane used in the method of the present invention is not particularly limited, and examples thereof include a flat membrane, a spiral membrane, and a hollow fiber. When irradiating the endocrine disrupting substance-containing water with ultraviolet rays, flat membranes and hollow fibers can be suitably used.
【0006】本発明方法に用いる疎水性膜に触媒機能を
付与する方法に特に制限はなく、例えば、酸化還元触媒
を膜材料に練り込んで製膜することができ、あるいは、
表面をエッチングなどで親水性化して改質した疎水性膜
に酸化還元触媒を担持させることもできる。これらの中
で、表面を親水性化した疎水性膜に酸化還元触媒を担持
させる方法を好適に用いることができる。疎水性膜の表
面を親水性化する方法に特に制限はなく、例えば、疎水
性膜がポリテトラフルオロエチレン膜である場合は、膜
表面に親水性基を有するフッ素化合物の被覆層を形成す
ることができ、あるいは、膜表面に親水性単量体をグラ
フト重合することができる。被覆層を形成する親水性基
を有するフッ素化合物としては、例えば、テトラフルオ
ロエチレンと酢酸ビニルの共重合体の加水分解物などを
挙げることができ、グラフト重合させる親水性単量体と
しては、例えば、N−ビニルピロリドンなどを挙げるこ
とができる。疎水性膜の表面は、全体を親水性化する必
要はなく、膜表面の1〜6割程度が親水性化されていれ
ばよく、親水性化された部分に触媒が担持されることに
より、本発明の効果が発揮される。表面を親水性化した
疎水性膜に担持させる酸化還元触媒としては、例えば、
パラジウム、プラチナ、ルテニウム、ロジウム、イリジ
ウム、鉄、ニッケル、マンガン、銅などの金属触媒、チ
タニア、アルミナ、ジルコニア、過酸化ニッケル、過酸
化銅、過酸化コバルトなどの金属酸化物触媒などを挙げ
ることができる。疎水性膜への触媒の担持量に特に制限
はなく、例えば、疎水性膜の重量あたり0.05〜20
重量%を担持させることができる。触媒を担持させる方
法に特に制限はなく、例えば、疎水性膜を触媒金属を含
有する水溶液に浸漬するなどの方法により担持させるこ
とができる。疎水性膜がポリテトラフルオロエチレン膜
やポリフッ化ビニリデン膜のような耐熱性膜の場合、触
媒を含有する溶液に浸漬後、膜を100〜200℃で2
0〜30分加熱したり、あるいは、膜を上記の溶液に浸
漬したまま溶液を加熱することにより、膜への触媒の結
合強度を高めることができる。There is no particular limitation on the method of imparting a catalytic function to the hydrophobic film used in the method of the present invention. For example, a film can be formed by kneading an oxidation-reduction catalyst into a film material, or
An oxidation-reduction catalyst can also be supported on a hydrophobic film whose surface has been modified to be hydrophilic by etching or the like. Among them, a method in which a redox catalyst is supported on a hydrophobic film having a hydrophilic surface can be preferably used. The method for making the surface of the hydrophobic film hydrophilic is not particularly limited. For example, when the hydrophobic film is a polytetrafluoroethylene film, a coating layer of a fluorine compound having a hydrophilic group is formed on the film surface. Alternatively, a hydrophilic monomer can be graft-polymerized on the film surface. Examples of the fluorine compound having a hydrophilic group that forms the coating layer include, for example, a hydrolyzate of a copolymer of tetrafluoroethylene and vinyl acetate, and examples of the hydrophilic monomer to be graft-polymerized include: , N-vinylpyrrolidone and the like. The surface of the hydrophobic membrane does not need to be entirely hydrophilic, and it is sufficient that about 10 to 60% of the membrane surface is hydrophilic, and the catalyst is supported on the hydrophilized portion. The effects of the present invention are exhibited. As an oxidation-reduction catalyst to be supported on a hydrophobic membrane having a hydrophilic surface, for example,
Metal catalysts such as palladium, platinum, ruthenium, rhodium, iridium, iron, nickel, manganese, and copper, and metal oxide catalysts such as titania, alumina, zirconia, nickel peroxide, copper peroxide, and cobalt peroxide may be mentioned. it can. The amount of the catalyst supported on the hydrophobic membrane is not particularly limited, and is, for example, 0.05 to 20 per weight of the hydrophobic membrane.
% By weight. The method for supporting the catalyst is not particularly limited. For example, the catalyst can be supported by immersing the hydrophobic film in an aqueous solution containing a catalyst metal. When the hydrophobic film is a heat-resistant film such as a polytetrafluoroethylene film or a polyvinylidene fluoride film, the film is immersed in a solution containing a catalyst and then heated at 100 to 200 ° C. for 2 hours.
By heating for 0 to 30 minutes, or by heating the solution while immersing the membrane in the above solution, the bonding strength of the catalyst to the membrane can be increased.
【0007】本発明方法において、内分泌撹乱性物質含
有水に添加する酸化剤に特に制限はなく、例えば、過酸
化水素、オゾン、酸素、塩素、過硫酸などを挙げること
ができる。酸化分解により、カドミウムや鉛などの無機
物を除く内分泌撹乱性物質全般を除去することができ
る。酸化分解に際しては、ニッケル、コバルト、パラジ
ウム、プラチナ、鉄、マンガンなどの単体や、酸化物、
過酸化物触媒を用いることが好ましい。酸化剤の添加量
に特に制限はないが、水中の内分泌撹乱性物質の全量を
酸化分解するために必要な化学理論量の1〜3倍である
ことが好ましい。本発明方法において、内分泌撹乱性物
質含有水に添加する還元剤に特に制限はなく、例えば、
水素、ヒドラジン、ヒドロキシルアミン、アンモニア、
メタノールなどを挙げることができる。還元分解によ
り、内分泌撹乱性物質のうち、有機塩素系化合物を脱塩
素して除去することができる。還元分解に際しては、プ
ラチナ、パラジウム、ルテニウム、ロジウム、鉄、銅、
イリジウム、ニッケルなどの触媒を用いることが好まし
い。内分泌撹乱性物質を還元分解するための還元剤の添
加量に特に制限はないが、吸着された内分泌撹乱性物質
を完全に還元分解又は脱塩素するために必要な化学理論
量の1〜2倍であることが好ましい。本発明方法におい
ては、内分泌撹乱性物質含有水に酸化剤を添加し、又は
添加せず、紫外線照射下に触媒機能を有する疎水性膜に
通水することができる。酸化剤を添加する場合、添加す
る酸化剤の種類及び添加量は、紫外線照射を行わず酸化
分解を行う場合と同様でよい。照射する紫外線の線源に
特に制限はなく、例えば、低圧水銀ランプ、中圧水銀ラ
ンプ、高圧水銀ランプ、キセノンランプ、重水素ラン
プ、メタルハライドランプなどを挙げることができる。
紫外線照射を行うことにより、酸化分解反応を促進する
とともに、光分解により、カドミウムや鉛などの無機物
を除く内分泌撹乱性物質全般を酸化して除去することが
できる。光分解に際しては、チタニア、ジルコニアなど
の紫外線を受けて分解活性を示す光触媒を用いることが
好ましい。In the method of the present invention, the oxidizing agent added to the endocrine disrupting substance-containing water is not particularly limited, and examples thereof include hydrogen peroxide, ozone, oxygen, chlorine, and persulfuric acid. By oxidative decomposition, it is possible to remove all endocrine disrupting substances except inorganic substances such as cadmium and lead. In the case of oxidative decomposition, nickel, cobalt, palladium, platinum, iron, manganese and other simple substances, oxides,
It is preferable to use a peroxide catalyst. The amount of the oxidizing agent is not particularly limited, but is preferably 1 to 3 times the stoichiometric amount necessary for oxidatively decomposing the entire amount of endocrine disrupting substance in water. In the method of the present invention, the reducing agent to be added to the endocrine disrupting substance-containing water is not particularly limited, for example,
Hydrogen, hydrazine, hydroxylamine, ammonia,
Methanol and the like can be mentioned. By reductive decomposition, among endocrine disrupting substances, organochlorine compounds can be dechlorinated and removed. For reductive decomposition, platinum, palladium, ruthenium, rhodium, iron, copper,
It is preferable to use a catalyst such as iridium or nickel. The amount of the reducing agent added for reductive decomposition of the endocrine disrupting substance is not particularly limited, but is 1 to 2 times the stoichiometric amount required to completely reduce or decompose the adsorbed endocrine disrupting substance. It is preferred that In the method of the present invention, water can be passed through a hydrophobic membrane having a catalytic function under ultraviolet irradiation, with or without the addition of an oxidizing agent to water containing endocrine disrupting substances. When an oxidizing agent is added, the type and amount of the oxidizing agent to be added may be the same as in the case where oxidative decomposition is performed without irradiation with ultraviolet light. There is no particular limitation on the source of ultraviolet light to be irradiated, and examples thereof include a low-pressure mercury lamp, a medium-pressure mercury lamp, a high-pressure mercury lamp, a xenon lamp, a deuterium lamp, and a metal halide lamp.
By irradiating with ultraviolet rays, the oxidative decomposition reaction can be promoted, and by photolysis, endocrine disrupting substances other than inorganic substances such as cadmium and lead can be oxidized and removed in general. At the time of photodecomposition, it is preferable to use a photocatalyst such as titania or zirconia, which has a decomposing activity upon receiving ultraviolet rays.
【0008】本発明方法の実施に際しては、内分泌撹乱
性物質含有水の触媒機能を有する疎水性膜への通水に先
だって、凝集沈殿、ろ過などにより、内分泌撹乱性物質
含有水中の懸濁物質を除去することが好ましい。あらか
じめ懸濁物質を除去することにより、疎水性膜の汚染を
防いで長期にわたる処理が可能になり、処理水である膜
透過水の水質が向上し、添加する酸化剤が無駄に消費さ
れることを防ぐことができる。図1は、本発明方法の実
施の一態様の工程系統図である。前処理によって懸濁物
質が除去された原水に、酸化剤が添加され、触媒機能を
有する疎水性膜を備えたろ過膜装置1に送られる。疎水
性膜を透過した膜透過水は、内分泌撹乱性物質が分解除
去されている。ろ過膜装置の濃縮水は、ろ過膜装置の供
給水の配管に返送され、ふたたびろ過装置に送られて処
理される。図2は、本発明方法の他の態様の工程系統図
である。前処理によって懸濁物質が除去された原水が、
流入水側に紫外線ランプ2が設置されたろ過膜装置1に
送られる。疎水性膜を透過した膜透過水は、内分泌撹乱
性物質が分解除去されている。ろ過膜装置の濃縮水は、
ろ過膜装置の供給水の配管に返送され、ふたたびろ過装
置に送られて処理される。本発明方法によって内分泌撹
乱性物質が効果的に分解除去される理由は明らかではな
いが、下記の機構によるものと推測される。すなわち、
多くの内分泌撹乱性物質は疎水性であるために、内分泌
撹乱性物質含有水が疎水性膜に通水されたとき、水中の
親水性物質は速やかに膜を通過するが、内分泌撹乱性物
質は疎水性膜の表面及び孔壁への吸着と脱着を繰り返し
ながら緩やかに通過する。このために、内分泌撹乱性物
質は、疎水性膜に担持された酸化還元触媒の作用を受
け、添加された酸化剤又は還元剤と反応して分解除去さ
れる。水中に含まれる親水性物質は、疎水性膜を速やか
に通過するので、親水性物質の分解のために費やされる
酸化剤又は還元剤の量は少なく、酸化剤や還元剤の無駄
な消費が抑えられ、水中に含有される低濃度の内分泌撹
乱性物質を効率よく分解除去することができる。触媒機
能を有する膜が親水性膜である場合は、水中の親水性物
質の方が優先的に分解されるので、内分泌撹乱性物質の
分解除去率は低下する。[0008] In carrying out the method of the present invention, prior to the passage of the water containing endocrine disrupting substance through the hydrophobic membrane having a catalytic function, the suspended substance in the water containing endocrine disrupting substance is subjected to coagulation sedimentation and filtration. Removal is preferred. Preliminary removal of suspended substances prevents contamination of the hydrophobic membrane, enabling long-term treatment, improving the quality of the permeated water that is treated water, and wastefully using the oxidizing agent to be added. Can be prevented. FIG. 1 is a process flow chart of an embodiment of the method of the present invention. An oxidizing agent is added to the raw water from which suspended substances have been removed by the pretreatment, and the raw water is sent to the filtration membrane device 1 provided with a hydrophobic membrane having a catalytic function. In the permeated water that has passed through the hydrophobic membrane, endocrine disrupting substances are decomposed and removed. The concentrated water of the filtration membrane device is returned to the supply water pipe of the filtration membrane device, and is again sent to the filtration device for processing. FIG. 2 is a process flow chart of another embodiment of the method of the present invention. Raw water from which suspended substances have been removed by pretreatment,
It is sent to the filtration membrane device 1 in which the ultraviolet lamp 2 is installed on the inflow water side. In the permeated water that has passed through the hydrophobic membrane, endocrine disrupting substances are decomposed and removed. The concentrated water of the filtration membrane device is
The water is returned to the supply water pipe of the filtration membrane device, and is sent again to the filtration device for processing. The reason why the endocrine disrupting substance is effectively decomposed and removed by the method of the present invention is not clear, but is presumed to be due to the following mechanism. That is,
Since many endocrine disrupting substances are hydrophobic, when endocrine disrupting substance-containing water is passed through a hydrophobic membrane, hydrophilic substances in the water pass through the membrane quickly, but endocrine disrupting substances do not. It passes slowly while repeating adsorption and desorption to the surface of the hydrophobic membrane and the pore wall. To this end, the endocrine disrupting substance is decomposed and removed by the action of the oxidation-reduction catalyst supported on the hydrophobic membrane and reacting with the added oxidizing or reducing agent. Since the hydrophilic substance contained in the water passes through the hydrophobic membrane quickly, the amount of the oxidizing agent or the reducing agent consumed for the decomposition of the hydrophilic substance is small, and the wasteful consumption of the oxidizing agent or the reducing agent is suppressed. As a result, low-concentration endocrine disrupting substances contained in water can be efficiently decomposed and removed. When the membrane having the catalytic function is a hydrophilic membrane, the hydrophilic substance in water is decomposed more preferentially, so that the rate of decomposing and removing endocrine disrupting substances is reduced.
【0009】[0009]
【実施例】以下に、実施例を挙げて本発明をさらに詳細
に説明するが、本発明はこれらの実施例によりなんら限
定されるものではない。 実施例1 孔径0.1μmのポリテトラフルオロエチレン精密ろ過
膜を、テトラフルオロエチレン/ビニルアルコール共重
合体の0.1重量%メチルアルコール溶液に浸漬した。
浸漬後、膜を110℃で乾燥させて膜表面の一部を親水
性化した。親水性化された部分は、膜表面全体の約2割
であった。この膜を硫酸ニッケル水溶液に浸漬して蒸発
乾固させることにより、ニッケルを膜に対して1重量%
となるように担持させた。次に、これを次亜塩素酸ナト
リウムと水酸化ナトリウムの水溶液に浸漬して活性化処
理を行い、過酸化ニッケル担持ポリテトラフルオロエチ
レン精密ろ過膜を得た。このろ過膜を用いて、膜面積2
0cm2のろ過装置を作製した。河川表流水10リットル
に、ノニルフェノールを濃度が40μg/リットルにな
るように添加して試験水とし、上記のろ過装置を用い
て、図1に示す工程によりノニルフェノールの分解処理
を行った。試験水に、オゾンを濃度が1mg/リットルに
なるように溶解し、ろ過装置にろ過体積速度10ml/cm
2・hで通水した。24時間後、ノニルフェノール濃度
を、固相抽出−GC/MS法で測定したところ、膜透過
水は0.1μg/リットル以下、濃縮水は4μg/リッ
トルであった。 実施例2 過酸化ニッケル担持ポリテトラフルオロエチレン精密ろ
過膜(孔径0.1μm)の代わりに、塩化パラジウム水
溶液に浸漬し、パラジウムを膜に対して1重量%となる
ように担持させたパラジウム担持ポリテトラフルオロエ
チレン精密ろ過膜(孔径0.1μm)を用いた以外は、
実施例1と同じ操作を繰り返した。24時間後のノニル
フェノール濃度は、膜透過水は0.1μg/リットル以
下、濃縮水は4μg/リットルであった。 実施例3 実施例2で用いたパラジウム担持ポリテトラフルオロエ
チレンろ過膜を装着したろ過膜装置に、河川表流水10
リットルに2,4−ジクロロフェノールを濃度40μg
/リットルになるように添加した試験水に、水素ガスを
濃度が1mg/リットルになるように溶解し、80℃で通
水した。24時間後の2,4−ジクロロフェノールの濃
度は、膜透過水が0.1μg/リットル以下、濃縮水が
5μg/リットルであった。 実施例4 チタンイソプロポキシドとイソプロパノールの混合溶液
を5℃で2時間撹拌したのち、モル比がチタンイソプロ
ポキシド:イソプロパノール:超純水=1:10:4と
なるように調整して4時間加水分解反応させた。反応
後、吸引ろ過し、100℃で通気乾燥してアモルファス
酸化チタン微粒子を得た。アモルファス酸化チタン微粒
子に過酸化水素水を添加し、2時間撹拌して酸化チタン
ゾルを得た。このゾルに、さらに過酸化水素水を添加し
30分撹拌させ、酸化チタンコーティング溶液を得た。
実施例1と同様にして得た表面を一部親水性化したポリ
テトラフルオロエチレン精密ろ過膜を、上記の酸化チタ
ンコーティング溶液に浸漬し、250℃で焼成して得た
酸化チタン担持ポリテトラフルオロエチレン精密ろ過膜
を用いて、図2に示すろ過膜装置を作製した。ろ過膜装
置の流入水側には、合計で10kWの低圧水銀紫外線ラン
プを設けて紫外線照射を行った。このろ過膜装置に、実
施例1で用いた試験水にオゾンを添加せず、実施例1と
同じ速度で通水した。24時間後のノニルフェノール濃
度は、膜透過水が0.1μg/リットル以下、濃縮水が
7μg/リットルであった。 比較例1 実施例1で用いた膜表面の一部を親水性化したポリテト
ラフルオロエチレン精密ろ過膜の代わりに、孔径0.1
μmのセラミック精密ろ過膜を硫酸ニッケル水溶液に浸
漬して得た過酸化ニッケルを担持した親水性のセラミッ
ク精密ろ過膜を用いた以外は、実施例1と同じ操作を繰
り返した。24時間後のノニルフェノール濃度は、膜透
過水は4μg/リットル、濃縮水は1μg/リットルで
あった。実施例1〜4及び比較例1の結果を、第1表に
示す。EXAMPLES The present invention will be described in more detail with reference to the following Examples, which should not be construed as limiting the present invention. Example 1 A polytetrafluoroethylene microfiltration membrane having a pore size of 0.1 μm was immersed in a 0.1% by weight methyl alcohol solution of a tetrafluoroethylene / vinyl alcohol copolymer.
After immersion, the film was dried at 110 ° C. to make a part of the film surface hydrophilic. The hydrophilized portion was about 20% of the entire membrane surface. This film was immersed in an aqueous solution of nickel sulfate and evaporated to dryness, so that nickel was 1% by weight of the film.
It was carried so that it might become. Next, this was immersed in an aqueous solution of sodium hypochlorite and sodium hydroxide to perform an activation treatment, thereby obtaining a polytetrafluoroethylene microfiltration membrane supporting nickel peroxide. Using this filtration membrane, membrane area 2
A 0 cm 2 filter was made. Nonylphenol was added to 10 liters of river surface water so as to have a concentration of 40 μg / liter to prepare test water, and nonylphenol was subjected to a decomposition treatment using the above-described filtration device according to the process shown in FIG. Ozone was dissolved in the test water so that the concentration became 1 mg / liter, and a filtration volume rate of 10 ml / cm was added to the filtration device.
Water was passed for 2 hours. After 24 hours, the concentration of nonylphenol was measured by solid phase extraction-GC / MS method. As a result, the permeated water was 0.1 μg / liter or less and the concentrated water was 4 μg / liter. Example 2 Instead of a polytetrafluoroethylene microfiltration membrane (pore diameter: 0.1 μm) carrying nickel peroxide, the membrane was immersed in an aqueous solution of palladium chloride, and palladium was carried on the membrane so as to be 1% by weight of palladium. Except for using a tetrafluoroethylene microfiltration membrane (pore size 0.1 μm),
The same operation as in Example 1 was repeated. After 24 hours, the concentration of nonylphenol in the membrane permeated water was 0.1 μg / liter or less, and the concentration of the concentrated water was 4 μg / liter. Example 3 River surface water 10 was installed in a filtration membrane device equipped with a palladium-supported polytetrafluoroethylene filtration membrane used in Example 2.
2,4-dichlorophenol at a concentration of 40 μg per liter
/ L was dissolved in test water added so that the concentration became 1 mg / L, and the solution was passed at 80 ° C. Twenty-four hours later, the concentration of 2,4-dichlorophenol was 0.1 μg / liter or less for permeated water and 5 μg / liter for concentrated water. Example 4 After a mixed solution of titanium isopropoxide and isopropanol was stirred at 5 ° C. for 2 hours, the molar ratio was adjusted to be titanium isopropoxide: isopropanol: ultra pure water = 1: 10: 4 for 4 hours. The hydrolysis reaction was performed. After the reaction, the mixture was suction-filtered and dried at 100 ° C. under aeration to obtain amorphous titanium oxide fine particles. Hydrogen peroxide solution was added to the amorphous titanium oxide fine particles and stirred for 2 hours to obtain a titanium oxide sol. Hydrogen peroxide solution was further added to this sol and stirred for 30 minutes to obtain a titanium oxide coating solution.
The polytetrafluoroethylene microfiltration membrane partially hydrophilized obtained in the same manner as in Example 1 was immersed in the above-mentioned titanium oxide coating solution, and calcined at 250 ° C. to obtain polytetrafluoroethylene supported on titanium oxide. Using an ethylene microfiltration membrane, a filtration membrane device shown in FIG. 2 was produced. A low-pressure mercury ultraviolet lamp of 10 kW in total was provided on the inflow water side of the filtration membrane device to perform ultraviolet irradiation. The test water used in Example 1 was passed through the filter membrane device at the same speed as in Example 1 without adding ozone. After 24 hours, the concentration of nonylphenol was 0.1 μg / liter or less for permeated water and 7 μg / liter for concentrated water. Comparative Example 1 Instead of the polytetrafluoroethylene microfiltration membrane in which part of the membrane surface used in Example 1 was made hydrophilic, a pore size of 0.1 was used.
The same operation as in Example 1 was repeated, except that a hydrophilic ceramic microfiltration membrane carrying nickel peroxide obtained by immersing a μm ceramic microfiltration membrane in an aqueous nickel sulfate solution was used. After 24 hours, the concentration of nonylphenol was 4 μg / liter for permeated water and 1 μg / liter for concentrated water. Table 1 shows the results of Examples 1 to 4 and Comparative Example 1.
【0010】[0010]
【表1】 [Table 1]
【0011】第1表に見られるように、ノニルフェノー
ルを含有する試験水にオゾンを添加して、過酸化ニッケ
ルを担持した疎水性のポリテトラフルオロエチレン膜に
通水した実施例1、ノニルフェノールを含有する試験水
にオゾンを添加してパラジウムを担持したポリテトラフ
ルオロエチレン膜に通水した実施例2、2,4−ジクロ
ロフェノールを含有する試験水に水素ガスを添加してパ
ラジウム担持ポリテトラフルオロエチレン膜に通水した
実施例3、ノニルフェノールを含有する試験水を紫外線
照射下に酸化チタン担持ポリテトラフルオロエチレン膜
に通水した実施例4においては、膜透過水のノニルフェ
ノール濃度又は2,4−ジクロロフェノール濃度はいず
れも0.1μg/リットル以下となり、ノニルフェノー
ル又は2,4−ジクロロフェノールはほぼ完全に除去さ
れている。これに対して、ノニルフェノールとオゾンの
濃度が実施例1と同じであっても、過酸化ニッケルを担
持した親水性のセラミック膜に通水した比較例1におい
ては、膜透過水のノニルフェノール濃度は4μg/リッ
トルであり、親水性膜では、疎水性膜に比べてノニルフ
ェノールの分解が不十分となることが分かる。As can be seen from Table 1, ozone was added to test water containing nonylphenol, and water was passed through a hydrophobic polytetrafluoroethylene membrane carrying nickel peroxide. Example 2, in which ozone was added to test water to be tested and water was passed through a polytetrafluoroethylene membrane carrying palladium, hydrogen gas was added to test water containing 2,2,4-dichlorophenol, and polytetrafluoroethylene supported on palladium was added. In Example 3 in which water was passed through the membrane, and in Example 4 in which test water containing nonylphenol was passed through the titanium oxide-supported polytetrafluoroethylene membrane under ultraviolet irradiation, the nonylphenol concentration in the membrane permeated water or 2,4-dichloromethane was measured. The phenol concentration was 0.1 μg / liter or less in all cases, and nonylphenol or 2,4-dichloro Phenol is almost completely removed. On the other hand, even in the case where the concentrations of nonylphenol and ozone were the same as those in Example 1, in Comparative Example 1 in which water passed through the hydrophilic ceramic membrane supporting nickel peroxide, the nonylphenol concentration of the membrane permeated water was 4 μg. Per liter, which indicates that nonylphenol is insufficiently decomposed by the hydrophilic film compared to the hydrophobic film.
【0012】[0012]
【発明の効果】本発明方法によれば、水中に微量に含ま
れる内分泌撹乱性物質を選択的に分解除去して、低コス
トで無害化することができる。According to the method of the present invention, an endocrine disrupting substance contained in a trace amount in water can be selectively decomposed and removed, thereby making it harmless at low cost.
【図1】図1は、本発明方法の実施の一態様の工程系統
図である。FIG. 1 is a process flow chart of an embodiment of the method of the present invention.
【図2】図2は、本発明方法の実施の他の態様の工程系
統図である。FIG. 2 is a process flow chart of another embodiment of the method of the present invention.
1 ろ過膜装置 2 紫外線ランプ 1 Filtration membrane device 2 UV lamp
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) C02F 1/70 C02F 1/70 1/72 1/72 101 101 (72)発明者 村松 勇一 東京都新宿区西新宿三丁目4番7号 栗田 工業株式会社内 (72)発明者 松渓 直樹 東京都新宿区西新宿三丁目4番7号 栗田 工業株式会社内 Fターム(参考) 4D006 GA07 KA02 KA33 KA63 KB04 KB13 KB14 KB30 KD01 KD02 KD21 KD22 KD23 KD28 KD30 KE05P KE11Q KE12P KE13P KE14P MA01 MA03 MA22 MB10 MB11 MC22 MC23 MC29 MC30X MC33X MC46 MC65 MC90 NA54 NA60 NA63 PA01 PB04 PB70 4D038 AA02 AB08 AB09 AB11 AB14 BA02 BA06 BB07 BB09 BB13 BB15 BB16 BB17 BB18 4D050 AA02 AB12 AB13 AB15 AB19 BA08 BA09 BA14 BA20 BB01 BB02 BB05 BB13 BC06 BC07 BC09 BD02 BD08 CA09 CA13 CA15 CA16 ──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme court ゛ (Reference) C02F 1/70 C02F 1/70 1/72 1/72 101 101 (72) Inventor Yuichi Muramatsu Shinjuku-ku, Tokyo 3-7 Nishi Shinjuku Kurita Kogyo Co., Ltd. (72) Inventor Naoki Matsukei 3-4-7 Nishi Shinjuku Nishi Shinjuku, Shinjuku-ku, Tokyo F-term inside Kurita Kogyo Co., Ltd. KB30 KD01 KD02 KD21 KD22 KD23 KD28 KD30 KE05P KE11Q KE12P KE13P KE14P MA01 MA03 MA22 MB10 MB11 MC22 MC23 MC29 MC30X MC33X MC46 MC65 MC90 NA54 NA60 NA63 PA01 PB04 PB70 4D038 AA02 AB08 BB13 AB11 AB18 AB09 AB13 AB15 AB19 BA08 BA09 BA14 BA20 BB01 BB02 BB05 BB13 BC06 BC07 BC09 BD02 BD08 CA09 CA13 CA15 CA16
Claims (6)
する疎水性膜に通水することを特徴とする内分泌撹乱性
物質含有水の処理方法。1. A method for treating endocrine disrupting substance-containing water, which comprises passing the endocrine disrupting substance-containing water through a hydrophobic membrane having a catalytic function.
し、触媒機能を有する疎水性膜に通水する請求項1記載
の内分泌撹乱性物質含有水の処理方法。2. The method for treating endocrine disrupting substance-containing water according to claim 1, wherein an oxidizing agent is added to the endocrine disrupting substance-containing water and the water is passed through a hydrophobic membrane having a catalytic function.
し、紫外線照射下に触媒機能を有する疎水性膜に通水す
る請求項2記載の内分泌撹乱性物質含有水の処理方法。3. The method for treating endocrine disrupting substance-containing water according to claim 2, wherein an oxidizing agent is added to the endocrine disrupting substance-containing water and water is passed through a hydrophobic membrane having a catalytic function under irradiation with ultraviolet rays.
に触媒機能を有する疎水性膜に通水する請求項1記載の
内分泌撹乱性物質含有水の処理方法。4. The method for treating water containing endocrine disrupting substance according to claim 1, wherein the water containing endocrine disrupting substance is passed through a hydrophobic membrane having a catalytic function under ultraviolet irradiation.
し、触媒機能を有する疎水性膜に通水する請求項1記載
の内分泌撹乱性物質含有水の処理方法。5. The method for treating endocrine disrupting substance-containing water according to claim 1, wherein a reducing agent is added to the endocrine disrupting substance-containing water and the water is passed through a hydrophobic membrane having a catalytic function.
性化した疎水性膜に金属又は金属酸化物の触媒を担持さ
せたものである請求項1記載の内分泌撹乱性物質含有水
の処理方法。6. The water containing an endocrine disrupting substance according to claim 1, wherein the hydrophobic membrane having a catalytic function is obtained by carrying a metal or metal oxide catalyst on a hydrophobic membrane having a hydrophilic surface. Processing method.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11228034A JP2001047044A (en) | 1999-08-11 | 1999-08-11 | Method for treating water containing endocrine disrupting substances |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11228034A JP2001047044A (en) | 1999-08-11 | 1999-08-11 | Method for treating water containing endocrine disrupting substances |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2001047044A true JP2001047044A (en) | 2001-02-20 |
Family
ID=16870172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11228034A Pending JP2001047044A (en) | 1999-08-11 | 1999-08-11 | Method for treating water containing endocrine disrupting substances |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001047044A (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001198584A (en) * | 1999-11-08 | 2001-07-24 | Kanagawa Acad Of Sci & Technol | Method and apparatus for removing a substance having a steroid skeleton |
| JP2002153891A (en) * | 2000-09-11 | 2002-05-28 | Mitsubishi Heavy Ind Ltd | Method and apparatus for treating wastewater containing hardly decomposable substances |
| JP2003071477A (en) * | 2001-08-30 | 2003-03-11 | Mitsubishi Heavy Ind Ltd | Hazardous substance treatment method, its apparatus, and wastewater treatment system |
| WO2006006340A1 (en) * | 2004-07-07 | 2006-01-19 | Kureha Corporation | Porous vinylidene fluoride resin membrane for water treatment and process for producing the same |
| WO2010013677A1 (en) * | 2008-07-28 | 2010-02-04 | 栗田工業株式会社 | Process and equipment for the treatment of water containing organic matter |
| JP2010214229A (en) * | 2009-03-13 | 2010-09-30 | Panasonic Electric Works Co Ltd | Method for manufacturing filter for water treatment apparatuses, filter for water treatment apparatus and water treatment apparatuses |
| JP2011167633A (en) * | 2010-02-18 | 2011-09-01 | Kurita Water Ind Ltd | Water treatment method and apparatus |
| JP2012525247A (en) * | 2009-04-30 | 2012-10-22 | ロワラ | Purification method and apparatus for removing xenobiotics in water |
| CN112010475A (en) * | 2019-05-31 | 2020-12-01 | 中国石油化工股份有限公司 | A kind of photocatalysis and membrane catalysis combined water treatment method and device |
| CN115571968A (en) * | 2022-10-12 | 2023-01-06 | 生态环境部南京环境科学研究所 | By using Co 2+ Method for removing 2-chlorophenol in wastewater by catalyzing PMS |
-
1999
- 1999-08-11 JP JP11228034A patent/JP2001047044A/en active Pending
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001198584A (en) * | 1999-11-08 | 2001-07-24 | Kanagawa Acad Of Sci & Technol | Method and apparatus for removing a substance having a steroid skeleton |
| JP2002153891A (en) * | 2000-09-11 | 2002-05-28 | Mitsubishi Heavy Ind Ltd | Method and apparatus for treating wastewater containing hardly decomposable substances |
| JP2003071477A (en) * | 2001-08-30 | 2003-03-11 | Mitsubishi Heavy Ind Ltd | Hazardous substance treatment method, its apparatus, and wastewater treatment system |
| JP4864707B2 (en) * | 2004-07-07 | 2012-02-01 | 株式会社クレハ | Method for producing vinylidene fluoride resin porous water treatment membrane |
| WO2006006340A1 (en) * | 2004-07-07 | 2006-01-19 | Kureha Corporation | Porous vinylidene fluoride resin membrane for water treatment and process for producing the same |
| JPWO2006006340A1 (en) * | 2004-07-07 | 2008-04-24 | 株式会社クレハ | Vinylidene fluoride resin porous water treatment membrane and method for producing the same |
| US8771522B2 (en) | 2008-07-28 | 2014-07-08 | Kurita Water Industries Ltd. | Method and apparatus for treating organic matter-containing water |
| KR20110053946A (en) * | 2008-07-28 | 2011-05-24 | 쿠리타 고교 가부시키가이샤 | Method and apparatus for treating organic matter-containing water |
| JP5447378B2 (en) * | 2008-07-28 | 2014-03-19 | 栗田工業株式会社 | Method and apparatus for treating water containing organic matter |
| WO2010013677A1 (en) * | 2008-07-28 | 2010-02-04 | 栗田工業株式会社 | Process and equipment for the treatment of water containing organic matter |
| KR101692212B1 (en) | 2008-07-28 | 2017-01-03 | 쿠리타 고교 가부시키가이샤 | Process and equipment for the treatment of water containing organic matter |
| JP2010214229A (en) * | 2009-03-13 | 2010-09-30 | Panasonic Electric Works Co Ltd | Method for manufacturing filter for water treatment apparatuses, filter for water treatment apparatus and water treatment apparatuses |
| JP2012525247A (en) * | 2009-04-30 | 2012-10-22 | ロワラ | Purification method and apparatus for removing xenobiotics in water |
| JP2011167633A (en) * | 2010-02-18 | 2011-09-01 | Kurita Water Ind Ltd | Water treatment method and apparatus |
| CN112010475A (en) * | 2019-05-31 | 2020-12-01 | 中国石油化工股份有限公司 | A kind of photocatalysis and membrane catalysis combined water treatment method and device |
| CN115571968A (en) * | 2022-10-12 | 2023-01-06 | 生态环境部南京环境科学研究所 | By using Co 2+ Method for removing 2-chlorophenol in wastewater by catalyzing PMS |
| CN115571968B (en) * | 2022-10-12 | 2024-03-08 | 生态环境部南京环境科学研究所 | A method for removing 2-chlorophenol from wastewater using Co2+ catalyzed PMS |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Subramaniam et al. | Photocatalytic membranes: a new perspective for persistent organic pollutants removal | |
| Segneanu et al. | Waste water treatment methods | |
| CN1204060C (en) | Method for mineralization of organic pollutants in water by catalytic ozonization | |
| CN1144519A (en) | Oxidation process | |
| JP2001047044A (en) | Method for treating water containing endocrine disrupting substances | |
| JPH05154473A (en) | Photochemical reaction treatment for fluid | |
| JPH06510696A (en) | Wastewater treatment method and device | |
| Papac Zjačić et al. | Combined Application of Membrane and Advanced Oxidation Processes for Removal of Pharmaceuticals from Water. | |
| JP2008302308A (en) | Photocatalyst and production method thereof, water treatment method and apparatus using the same | |
| JP3118558B2 (en) | Water treatment catalyst and water treatment method | |
| JP2003080275A (en) | Method for treating organic halogen compound in water | |
| EP4208412A1 (en) | Wastewater ozone treatment | |
| CN114538597B (en) | Preparation and application of manganese-based membrane catalytic contactor for strengthening novel pollutants of ozone oxidation | |
| Ikhlaq et al. | Degradation of safranin by heterogeneous Fenton processes using peanut shell ash based catalyst | |
| JP3766298B2 (en) | Wastewater treatment method and apparatus | |
| JP2000254666A (en) | Method for treating water containing endocrine disrupting substances | |
| JP2000042575A (en) | Environmental hormone-containing water treatment method | |
| JP2001029944A (en) | Removal of nitrogen compounds from water | |
| JP2000189945A (en) | Method and apparatus for treating water containing endocrine disrupting substances | |
| JP2001232379A (en) | Method of treating waste water | |
| Meena | Photo catalytic degradation of textile Azo dye using newly developed photo catalyst | |
| Chen et al. | Hydrogen‐based tubular catalytic membrane for removing nitrate from groundwater | |
| JP2000254651A (en) | Electrolytic treatment method and electrolytic treatment device for water containing hydrophobic organic substance | |
| RU2203228C2 (en) | Method of cleaning and decontamination of water | |
| JP2000189959A (en) | Method and apparatus for treating water containing endocrine disrupting substances |